Author:
Yamada Shizuo,Kuraoka Shiori,Ito Yoshihiko,Kagota Satomi,Shinozuka Kazumasa,Onoue Satomi
Subject
Pharmacology,Molecular Medicine
Reference15 articles.
1. Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder;Yamada;Pharmacol Ther,2018
2. Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome;Michel;Expert Opin Pharmacother,2008
3. Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle;Yoshida;Urology,2013
4. Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administration;Yamada;J Pharmacol Sci,2019
5. In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder;Maruyama;Naunyn-Schmiedeberg’s Arch Pharmacol,2008